Join Now

Utah News About COVID-19

November 20, 2020
COVID-19 Vaccination Briefing From the State of Utah.

View the briefing below: COVID-19 Vaccination Update_11-17-2020

November 13, 2020
Utah Life Sciences Leaders Honored At 2020 Virtual Life Sciences Summit

On the last day of the Summit, BioUtah announced its 2020 Utah Life Sciences award winners, which were presented during a special virtual awards session. Gary Crocker, president of Crocker Ventures, was honored with a Lifetime Achievement Award Other distinguished award winners include Salt Lake City Mayor Erin Mendenhall; Chris Gibson, CEO, Recursion Pharmaceuticals; Randy Rasmussen, co-founder, […]

November 13, 2020
BioHive Launched at Utah Life Sciences Summit – Join the Campaign 

  The 11th annual Utah Life Sciences Summit (ULSS) Nov. 9-11, went virtual this year. But despite the physical distance, the ULSS made news and ignited our life sciences industry with a special announcement — the launch of BioHive, a new bold campaign to brand and expand Utah’s life sciences ecosystem. ICYMI…view the video and see […]

October 30, 2020
Dr. Dinesh C. Patel Honored with Utah Governor’s Lifetime Achievement Medal

Utah’s own life sciences entrepreneur, Dinesh C. Patel, PhD, has been honored with the Utah Governor’s Lifetime Achievement Medal for Science and Technology for his contribution in the field of biotechnology and pharmaceuticals. “This honor is well-deserved,” said Kelvyn Cullimore, president and CEO of BioUtah. “Dr. Patel has been instrumental in founding and bringing a […]

October 16, 2020
IDbyDNA and Illumina Launch New Rapid Test to Better Detect COVID-19, Flu, Respiratory Co-Infections

Utah-based IDbyDNA announced yesterday that, in an effort to help labs better identify respiratory pathogens and avoid overuse of antimicrobial drugs, IDbyDNA and Illumina, Inc. are co-launching the new Respiratory Pathogen ID/AMR Target Enrichment Assay. The test, currently for research use only, will improve testing for infectious diseases, including COVID-19, and will leverage IDbyDNA’s Explify® […]

October 16, 2020
SDP Oncology Announces First Patient Dosed in a Phase 1 Solid Tumor Study

Lehi-based Sumitomo Dainippon Pharma Oncology (SDP Oncology) recently announced that the first patient has been dosed with the PKM2 activator, TP-1454, in a Phase 1/1b study in patients with advanced metastatic or progressive solid tumors.  “Dosing the first patient in this study marks an important milestone, as TP-1454 is the first PKM2 activator to be […]

October 16, 2020
Governor Herbert Announces New COVID-19 Transmission Index

On Wednesday, Governor Herbert announced the state’s new response plan to COVID-19, effective October 15. This updated plan utilizes a COVID-19 Transmission Index and replaces the previous color-coded guidance system of red, orange, yellow and green. The new approach comes at a time when the state has seen a significant spike in infection rates. The […]

October 9, 2020
SINTX Technologies Develops New Mask Fabric with Silicon Nitride

On Tuesday, SINTX Technologies (SINTX) announced progress toward the manufacture of a “catch-and-kill” mask that will inactivate respiratory viruses. SINTX has successfully embedded silicon nitride particles into nonwoven and woven fabric fibers. Silicon nitride has been shown to neutralize several bacterial species and viral strains, including SARS-CoV-2.  “By investing in our human resources and equipment, […]

October 9, 2020
U OF U Establishes Partners For Innovation, Ventures, Outreach & Technology

U of U President Ruth V. Watkins announced on September 30 that the U has formed the Partners for Innovation, Ventures, Outreach & Technology (PIVOT) Center. This new centralized office builds on the work by the Center for Technology & Venture Commercialization (TVC) and will facilitate the U’s efforts to drive technology commercialization and economic […]

October 2, 2020
Utah Business Magazine Recognizes Recursion’s Tina Larson, Civica’s Heather Wall Among Utah’s Top C-Suite Executives

Recursion’s President and Chief Operating Officer, Tina Larson, and Civica’s Chief Commercial Officer, Heather Wall, were recently recognized by Utah Business Magazine as among Utah’s top C-Suite executives. In introducing the 2020 CXO of the Year honorees, the magazine notes that “now more than ever we need strong leaders to guide our businesses forward and […]

October 2, 2020
Foldax Named Finalist in the Fierce Innovation Awards

Salt Lake City-based Foldax® was a finalist in the recent Fierce Innovation Awards – Life Sciences Edition 2020, a peer-reviewed awards program from the publisher of Fierce Biotech and Fierce Pharma. The company was selected as a finalist for its innovative TriaTM heart valve. The Tria valve reimagines the heart valve by incorporating a new, […]

October 2, 2020
Alucent Biomedical Announces $35 Million Series B Financing

Alucent Biomedical, a Salt Lake-City based company and BioUtah member, founded to transform the way vascular disease is treated, yesterday announced the close of a $35 million Series B financing round. The funding will support two clinical trials to evaluate Alucent’s novel treatment for peripheral artery disease (PAD) of the lower extremities. PAD is a […]

September 18, 2020
Fulgent Genetics Lands Utah COVID-19 Testing Contract

TestUtah has some new twists. Following the expiration of certain state contracts September 1, the Utah Department of Public Health has changed direction and contracted with a Los Angeles laboratory, Fulgent Genetics, to process COVID-19 testing for Utahns under the state’s coronavirus testing initiative. The test, which has received EUA from the FDA, will be […]

September 18, 2020
The Point Kick Off

On Monday, government leaders, including Lt. Governor Spencer Cox, held a press conference announcing the launch of planning efforts to redevelop the site of the Utah State Prison (The Point) in Draper. Many of our industry leaders are participating on The Point’s Education, Research and Innovation working group – Randy Rasmussen (former BioFire CEO), Gary […]

September 11, 2020
Inherent Biosciences Wins $256K NSF Grant to predict COVID-19 infection severity and treatment response

Inherent Biosciences, a biotechnology company headquartered in Salt Lake City has announced a $255,959 award from the National Science Foundation (NSF) to study epigenetic biomarkers to predict patient response to COVID-19. The SBIR Phase I project aims to develop an onsite, clinical test to screen incoming patients potentially infected with COVID-19. The test would predict […]